The largest database of trusted experimental protocols

Poly l lysine hydrobromide pll

Manufactured by Merck Group
Sourced in France, United States

Poly-L-lysine hydrobromide (PLL) is a synthetic, cationic polymer used in various laboratory applications. It serves as a cell culture surface coating to promote cell adhesion and growth. PLL enhances the attachment of anchorage-dependent cell types by providing a positively charged substrate. The product is available in different molecular weight ranges.

Automatically generated - may contain errors

15 protocols using poly l lysine hydrobromide pll

1

Radiolabeled Peptide Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly-L-lysine hydrobromide (PLL) (MW range = 4000–15,000) and polyamidoamine (PAMAM) dendrimer with an ethylenediamine core (generation (G) 3) in methanol were purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA). Boc-Ser(tBu)-OH and HOBt were purchased from Watanabe Chemical Industries (Hiroshima, Japan). Hexafluorophosphate benzotriazole tetramethyl uronium (HBTU) was purchased from Merck Millipore (Burlington, MA, USA). Dimethyl sulfoxide (DMSO; super dehydrated grade), N,N-dimethylformamide (DMF; super dehydrated grade), N,N-diisopropylethylamine (DIPEA), piperidine, trifluoroacetic acid (TFA), triisopropylsilane (TIS), Turk’s solution, and poly-L-lysine hydrobromide (MW range = 15,000–30,000) were purchased from Fujifilm Wako Pure Chemical Industries Ltd. (Osaka, Japan). PD-10 was purchased from GE Healthcare Japan (Tokyo, Japan). The 111InCl3 was supplied by Nihon Medi-Physics (Tokyo, Japan). 90YCl3 was purchased from Eckert Radiopharma (Berlin, Germany). DTPA anhydride was purchased from Chemical Dojin Co., Ltd. (Kumamoto, Japan). All other chemicals were of commercial reagent grade.
+ Open protocol
+ Expand
2

Multilayer Biomaterial Scaffold Fabrication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(L-lysine) hydrobromide (PLL), poly(ethylene imine) (PEI), poly(L-glutamic) acid (PGA) were from Sigma-Alrich (St Quentin Fallavier, France), hyaluronic acid (HA) from Lifecore medical (USA). For biological functionalization, PGA-RGD was synthesized as previously described [36 ]. PLL, HA and PEI at respectively 0.5, 1 and 2 mg/mL were dissolved in a HEPES-NaCl buffer (20 mM Hepes at pH 7.4, 0.15 M NaCl). A first layer of PEI was always deposited. All rinsing steps were performed with 0.15 M NaCl at pH ~6.5. The films were chemically crosslinked using 1-Ethyl-3-(3-Dimethylamino-propyl)Carbodiimide (EDC, final concentration of 5, 10, 30 or 70 mg/mL depending of the films) and N-Hydrosulfosuccinimide sodium salt (Sulfo-NHS, 11 mg/mL) as catalyzer, as previously described [32 (link), 42 (link)]. BMP loading in the films was done following an established protocol [31 (link), 33 (link)].
+ Open protocol
+ Expand
3

Lipoplex Nanoparticle Encapsulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGluc vector (5764 bp) or pBMP2 vector (3486 bp) (100 μg) was complexed with 500 μg of Poly L-Lysine hydrobromide (PLL) (1000–5000 Da, Sigma, United Kingdom) by sequentially adding 10 μg of pDNA dropwise to 50 μg of PLL using a P200 pipette tip under vortexing. The working concentration was 40 and 200 μg/ml in nuclease-free water for pDNA and PLL, respectively. The mixture of pDNA-PLL NPs in a volume of 5 ml was then concentrated to 250 μl using Amicon® Ultra Centrifugal Filter units. This volume of the mixture of pDNA-PLL NPs was encapsulated in the PLGA NPs by double emulsion as below. The hydrodynamic size and surface charge of pDNA-PLL NPs were assessed by Malvern Zetasizer Nano ZS. NP morphology was determined by Transmission Electron Microscopy (FEI Tecnai BioTwin-12 TEM) as previously (Osman et al., 2018 (link)).
+ Open protocol
+ Expand
4

Transwell Assay for Macrophage Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The migration of the cultured macrophages was assessed by a transwell assay using 6.5 mm transwell chambers (8 µm pores, Corning Costar, New York, NY, USA, 3422) as described previously [25 (link),29 (link)]. After the chambers were pretreated with 0.1 mg/mL Poly-L-lysine hydrobromide (PLL, Sigma-Aldrich, St. Louis, MO, USA, P1274) solution or culture medium, 1 × 105 macrophages in 100 µL of DMEM/F12 containing 1% FBS were seeded into the upper chamber, and the lower chamber was filled with 600 µL DMEM/F12 containing 10% FBS and 1 mg/mL myelin debris without cells. The macrophages were allowed to migrate for 18 h, and then the chambers were fixed with 4% PFA for 20 min. After careful removal of the cells on the upper surface with a cotton swab, the cells adhered to the lower surface of the transwell membrane were stained with 0.1% crystal violet (Leagene, Beijing, China, DZ0055) for 30 min. Then, five images of each membrane (the center and four quadrants) were captured under an inverted microscope (Leica, Wetzlar, Germany) for quantification.
+ Open protocol
+ Expand
5

Labeling hBM-MSCs with SPIO Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bone marrow-derived mesenchymal stem cells (hBM-MSCs) (HMSC-bm 7500; ScienCell Research Laboratories, Carlsbad, CA, USA) were grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 200 mM L-glutamine, and 1% gentamicin reagent (all Invitrogen reagents; Invitrogen, Carlsbad, CA, USA) at 37℃, 5% CO2 atmosphere. The culture medium was replaced every 3 days and the cells were sub-cultured when 80-90% confluency was reached. To identify the cells using MRI, hBM-MSCs were labeled with 50 µg Fe/mL SPIO nanoparticles (Feridex IV; Advanced Magnetics Inc., Cambridge, MA, USA) by using a transfection agent, 750 ng/mL poly-L-lysine hydrobromide (PLL; Sigma, St. Louis, MO, USA) (5 (link)). To determine whether the cells were effectively labeled with SPIO, Prussian blue (PB) staining for ferric (Fe3+) iron was performed. PB staining has been described in the latter part of text.
+ Open protocol
+ Expand
6

Engineered Hyaluronic Acid-Based Biomaterials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, chemicals were used without further purification. Poly-L-lysine hydrobromide (PLL; Mw 30–70 kDa), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) ≥ 98.0% and N-hydroxysuccinimide (NHS) were obtained from Sigma-Aldrich. Hyaluronic acid (HA; Mw 6.4 kDa, 752 kDa and 1500 kDa) was purchased from Lifecore. We used Anti-CD44 antibody [KM201] (ab25340) and Mouse IgG1 Kappa [MOPC-21]-Isotype 1 (ab18443) from Abcam for the CD44 blocking. Recombinant Human CD44 His tag protein was purchased from Biorbyt. Phalloidin–tetramethylrhodamine B isothiocyanate (phalloidin–TRITC), 4,6-diamidino-2-phenyindole, dilactate (DAPI) from Sigma-Aldrich and the monoclonal antibody to CD44 from Acris-Antibodies were used for immunostaining. The secondary antibody, Alexa Fluor 488 Rabbit Anti-Mouse IgG, was obtained from Invitrogen. The primary antibody Cortactin (H-191), sc-11408, was obtained from Santa Cruz Biotechnology.
+ Open protocol
+ Expand
7

Electrospun PCL Membranes for Anti-Inflammatory Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCL membranes were synthesized by electrospinning as previously described [16 (link)]. PCL membranes were treated with Poly-L-lysine hydrobromide (PLL) (Sigma, St-Quentin, France) (100 µg/mL) and functionalized at the concentration of 100 µg/mL [11 (link)] with α-MSH peptide (HS-CH2CH2-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-COOH) (Neosystem, Strasbourg, France) covalently coupled to Poly-L-glutamic acid (PGA) (Sigma, St-Quentin, France), which leaves accessible the anti-inflammatory C-terminal sequence Lys11-Pro12-Val13 [1 (link),20 (link)]. All membranes were sterilized by 30 min exposure to UV light (254 nm, 30 W, distance 20 cm).
+ Open protocol
+ Expand
8

Polymer-Supplemented Cell Culture Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
High-molecular-weight (M.W.) soluble polymers and their final concentration in culture
medium (CiCM) were as follows: Poly-ethylene glycol (PEG) [M.W. 15000-25000, nacalai
tesque]: CiCM 0.5-1 mg/ml; polyvinyl alcohol (PVA) [M.W. 146000-186000, Sigma-Aldrich]:
CiCM 0.5-1 mg/ml; polyvinylpyrrolidone (PVP) [M.W. 360000, Sigma-Aldrich]: CiCM 1 mg/ml;
dextran (Dex) [M.W. 190000-230000, nacalai tesque]: CiCM 1 mg/ml; poly-γ-glutamic acid
(PGA) [M.W. 200000-500000, Wako Pure Chemical industry]: CiCM 1 mg/ml; chondroitin sulfate
C sodium salt (CSC) [M.W. 40000-80000,Wako Pure Chemical industry]: CiCM 0.5 mg/ml;
hyaluronic acid sodium salt (HRL) [M.W. not determined, Wako Pure Chemical industry]: CiCM
0.5 mg/ml; chondroitin sulfate A sodium salt (CSA) [M.W. 40000-80000, Sigma-Aldrich]: CiCM
0.5 mg/ml; dermatan sulfate sodium salt (DS) [M.W. 85000~100000, Tokyo Chemical Industry]:
CiCM 0.5 mg/ml; poly-L-lysine hydrobromide (PLL) [M.W. 30000-70000, Sigma-Aldrich] CiCM
5-50 μg/ml; poly-L-ornithine hydrobromide (PLO) [M.W. 30000-70000, Sigma-Aldrich]: CiCM
12.5 μg/ml; poly-D-lysine hydrobromide (PDL) [M.W. 30000-70000, Sigma-Aldrich]: CiCM 12.5
μg/ml; poly-L-histidine (PLH) [M.W. 5000-25000, Sigma-Aldrich]: CiCM 12.5 μg/ml.
+ Open protocol
+ Expand
9

Preparation of PLL Dispersions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly-L-lysine hydrobromide (PLL) with molecular weights 30–70 kDa and 70–150 kDa were obtained from Sigma–Aldrich Chemie (Steinheim, Germany). Dispersions of PLL at 0.001% and 0.01% (w/v) were prepared in a phosphate buffer (PB), which consisted of 0.67 g of Na2HPO4, 0.19 g of KH2PO4, and 8.00 g of NaCl in 1 l of deionized water. The pH of the dispersions was adjusted to 6.5.
+ Open protocol
+ Expand
10

Rhodamine-tagged PLL Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(L-lysine) hydrobromide (PLL), having nominal molecular weight of 15000−30000 g/mol, was purchased from Sigma and used as received. Phosphate buffer with a pH of 7.4 (0.008 M Na2HPO4 and 0.002 M KH2PO4), having a Debye length of κ−1 = 2 nm, was employed in most studies unless otherwise noted. Variations in ionic strength, having different Debye lengths, were achieved either by diluting this buffer with deionized (DI) water or by adding buffer salts at the same ratio of Na2HPO4 and KH2PO4. In select control studies, Rhodamine-tagged PLL was employed. The Rhodamine labeling followed established procedures for fluorophore−isothiocyanate labeling of protein65 (link) and employed Rhodamine B isothiocyanate from Sigma. Labeling was followed by dialysis to remove unreacted fluorophores and return the solution to the pH 7.4 phosphate buffer. The labeled polymer was lyophilized for storage and redissolved as needed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!